An Oklahoma judge ruled Monday that phramaceutical giant Johnson & Johnson is responsible for its role in perpetiuating the opioid crisis. (Photo: Cindy Shebley, Flickr, cc)
Aug 26, 2019
In the first decided case against a corporation accused of contributing to the opioid epidemic in the U.S., personal care and pharmaceutical giant Johnson & Johnson was ordered on Monday to pay $572 million in fines for its role in perpetuating the crisis.
Through contracts with poppy growers in Tasmania, the company supplied 60 percent of the ingredients that drug companies used in opioid painkillers like OxyContin, contributing to the deaths of about 400,000 Americans in the last two decades--including 388 Oklahoma residents just in 2017.
Opioid manufacturers are facing thousands of lawsuits across the country for aggressively marketing drugs like OxyContin, Vicodin, and Percocet as non-addictive and safe for long-term use for chronic pain--even though the drugs are chemically very similar to heroin.
Public health advocates applauded District Judge Thad Balkman for holding the company accountable for its role in flooding Oklahoma with enough opioids between 2006 and 2012 for every resident to have nearly 100 pills each annually in some areas.
\u201cAbout damn time. We can't accept living in a country where Americans are in jail for possessing marijuana\u2014but not a single Pharma exec has spent even a night behind bars for the opioid crisis. The least they can do is pay up.\u201d— Beto O'Rourke (@Beto O'Rourke) 1566851822
\u201cThis ruling against J&J on fueling the opioid crisis is interesting and significant. Same arguments can be used against gun manufacturers for fueling the gun violence epidemic we all now live with. We must be able to pursue our litigation against them.\nhttps://t.co/V0E3HB4xgA\u201d— Fred Guttenberg (@Fred Guttenberg) 1566852027
"Johnson & Johnson executives made the calculated and coldblooded decision that they were going to produce a mutant strain of poppy, corner the market and supply massive amounts of the active ingredients for other companies to manufacture opioids," said Oklahoma Attorney General Mike Hunter, who brought the case against the company.
\u201cMORE:\n\n"Johnson & Johnson executives made the calculated and coldblooded decision that they were going to produce a mutant strain of poppy, corner the market and supply massive amounts of the active ingredients for other companies to manufacture opioids," \u2014Oklahoma AG Mike Hunter\u201d— Bloomberg Quicktake (@Bloomberg Quicktake) 1566850127
Three executives at Purdue Pharma, the maker of OxyContin, were found guilty in 2007 of misleading doctors, patients, and regulators about the addictive nature of the drug, and were ordered to pay $34.5 million in fines, in addition to $600 million paid by the company. But the lawsuit against Johnson & Johnson is the first of about 2,000 pending cases filed in cities and towns across the country where officials and residents want to hold opioid makers and marketers accountable for the damage they did to communities.
"The opioid crisis has ravaged the state of Oklahoma," Balkman said before announcing his verdict. "It must be abated immediately."
Join Us: News for people demanding a better world
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
In the first decided case against a corporation accused of contributing to the opioid epidemic in the U.S., personal care and pharmaceutical giant Johnson & Johnson was ordered on Monday to pay $572 million in fines for its role in perpetuating the crisis.
Through contracts with poppy growers in Tasmania, the company supplied 60 percent of the ingredients that drug companies used in opioid painkillers like OxyContin, contributing to the deaths of about 400,000 Americans in the last two decades--including 388 Oklahoma residents just in 2017.
Opioid manufacturers are facing thousands of lawsuits across the country for aggressively marketing drugs like OxyContin, Vicodin, and Percocet as non-addictive and safe for long-term use for chronic pain--even though the drugs are chemically very similar to heroin.
Public health advocates applauded District Judge Thad Balkman for holding the company accountable for its role in flooding Oklahoma with enough opioids between 2006 and 2012 for every resident to have nearly 100 pills each annually in some areas.
\u201cAbout damn time. We can't accept living in a country where Americans are in jail for possessing marijuana\u2014but not a single Pharma exec has spent even a night behind bars for the opioid crisis. The least they can do is pay up.\u201d— Beto O'Rourke (@Beto O'Rourke) 1566851822
\u201cThis ruling against J&J on fueling the opioid crisis is interesting and significant. Same arguments can be used against gun manufacturers for fueling the gun violence epidemic we all now live with. We must be able to pursue our litigation against them.\nhttps://t.co/V0E3HB4xgA\u201d— Fred Guttenberg (@Fred Guttenberg) 1566852027
"Johnson & Johnson executives made the calculated and coldblooded decision that they were going to produce a mutant strain of poppy, corner the market and supply massive amounts of the active ingredients for other companies to manufacture opioids," said Oklahoma Attorney General Mike Hunter, who brought the case against the company.
\u201cMORE:\n\n"Johnson & Johnson executives made the calculated and coldblooded decision that they were going to produce a mutant strain of poppy, corner the market and supply massive amounts of the active ingredients for other companies to manufacture opioids," \u2014Oklahoma AG Mike Hunter\u201d— Bloomberg Quicktake (@Bloomberg Quicktake) 1566850127
Three executives at Purdue Pharma, the maker of OxyContin, were found guilty in 2007 of misleading doctors, patients, and regulators about the addictive nature of the drug, and were ordered to pay $34.5 million in fines, in addition to $600 million paid by the company. But the lawsuit against Johnson & Johnson is the first of about 2,000 pending cases filed in cities and towns across the country where officials and residents want to hold opioid makers and marketers accountable for the damage they did to communities.
"The opioid crisis has ravaged the state of Oklahoma," Balkman said before announcing his verdict. "It must be abated immediately."
In the first decided case against a corporation accused of contributing to the opioid epidemic in the U.S., personal care and pharmaceutical giant Johnson & Johnson was ordered on Monday to pay $572 million in fines for its role in perpetuating the crisis.
Through contracts with poppy growers in Tasmania, the company supplied 60 percent of the ingredients that drug companies used in opioid painkillers like OxyContin, contributing to the deaths of about 400,000 Americans in the last two decades--including 388 Oklahoma residents just in 2017.
Opioid manufacturers are facing thousands of lawsuits across the country for aggressively marketing drugs like OxyContin, Vicodin, and Percocet as non-addictive and safe for long-term use for chronic pain--even though the drugs are chemically very similar to heroin.
Public health advocates applauded District Judge Thad Balkman for holding the company accountable for its role in flooding Oklahoma with enough opioids between 2006 and 2012 for every resident to have nearly 100 pills each annually in some areas.
\u201cAbout damn time. We can't accept living in a country where Americans are in jail for possessing marijuana\u2014but not a single Pharma exec has spent even a night behind bars for the opioid crisis. The least they can do is pay up.\u201d— Beto O'Rourke (@Beto O'Rourke) 1566851822
\u201cThis ruling against J&J on fueling the opioid crisis is interesting and significant. Same arguments can be used against gun manufacturers for fueling the gun violence epidemic we all now live with. We must be able to pursue our litigation against them.\nhttps://t.co/V0E3HB4xgA\u201d— Fred Guttenberg (@Fred Guttenberg) 1566852027
"Johnson & Johnson executives made the calculated and coldblooded decision that they were going to produce a mutant strain of poppy, corner the market and supply massive amounts of the active ingredients for other companies to manufacture opioids," said Oklahoma Attorney General Mike Hunter, who brought the case against the company.
\u201cMORE:\n\n"Johnson & Johnson executives made the calculated and coldblooded decision that they were going to produce a mutant strain of poppy, corner the market and supply massive amounts of the active ingredients for other companies to manufacture opioids," \u2014Oklahoma AG Mike Hunter\u201d— Bloomberg Quicktake (@Bloomberg Quicktake) 1566850127
Three executives at Purdue Pharma, the maker of OxyContin, were found guilty in 2007 of misleading doctors, patients, and regulators about the addictive nature of the drug, and were ordered to pay $34.5 million in fines, in addition to $600 million paid by the company. But the lawsuit against Johnson & Johnson is the first of about 2,000 pending cases filed in cities and towns across the country where officials and residents want to hold opioid makers and marketers accountable for the damage they did to communities.
"The opioid crisis has ravaged the state of Oklahoma," Balkman said before announcing his verdict. "It must be abated immediately."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.